Stockscreener 앱 받기
3.29
3.47%
0.12
시간 외 거래:
3.29
전일 마감가:
$3.17
열려 있는:
$3.17
하루 거래량:
10,953
Relative Volume:
0.15
시가총액:
$211.85M
수익:
$64.49M
순이익/손실:
$-71.40M
주가수익비율:
-3.0183
EPS:
-1.09
순현금흐름:
$-52.00M
1주 성능:
-10.87%
1개월 성능:
-10.63%
6개월 성능:
-7.08%
1년 성능:
-33.87%
1일 변동 폭
$3.085
$3.46
1주일 범위
$3.05
$3.75
52주 변동 폭
$2.70
$6.28
Sophia Genetics Sa Stock (SOPH) Company Profile
SOPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.29 | 211.85M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
226.50 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.95 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.89 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.74 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.33 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Craig Hallum | Buy |
| 2024-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-03 | 개시 | BTIG Research | Buy |
| 2022-11-23 | 개시 | Credit Suisse | Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-17 | 개시 | Cowen | Outperform |
| 2021-08-17 | 개시 | Credit Suisse | Outperform |
| 2021-08-17 | 개시 | JP Morgan | Overweight |
| 2021-08-17 | 개시 | Morgan Stanley | Overweight |
모두보기
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
Precision Medicine Software Market: Global Expansion & Growth - openPR.com
Mesoblast (NASDAQ:MESO) & SOPHiA GENETICS (NASDAQ:SOPH) Financial Review - Defense World
SOPHiA GENETICS (SOPH) Upgraded to Buy: What Does It Mean for the Stock? - MSN
With A 25% Price Drop For SOPHiA GENETICS SA (NASDAQ:SOPH) You'll Still Get What You Pay For - Simply Wall St
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC - Barchart
SOPHiA GENETICS Hits Major AI Breakthrough: 2M Patient Genomic Profiles Analyzed Worldwide - Stock Titan
Two Use Cases for AI in Healthcare - Streetwise Reports
March 2025's Promising Penny Stocks To Consider - Simply Wall St
Blood Cancer Diagnostics Market Analysis Report 2025-2030, with Quest Diagnostics, Illumina, InVivoScribe, Asuragen, Danaher, Sequenta, SkylineDx, Bio-Rad Laboratories, Alercell & Sophia Genetics - Yahoo Finance
Precision Medicine Software Market Set for Global Expansion - openPR.com
Sophia Genetics at TD Cowen Conference: AI-Powered Growth Strategy By Investing.com - Investing.com UK
SOPHiA GENETICS : To Present at the NVIDIA GTC AI Conference -March 06, 2025 at 05:30 am EST - Marketscreener.com
BTIG cuts Sophia Genetics stock price target to $5, maintains buy - Investing.com Australia
Sophia Genetics SA (SOPH) Q4 2024 Earnings Call Highlights: Record Customer Growth Amidst ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Reports 2024 Financial Results - TipRanks
SOPHiA GENETICS Earnings Call: Mixed Results, Optimistic Outlook - TipRanks
Sophia Genetics SA reports results for the quarter ended December 31Earnings Summary - TradingView
SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Sophia Genetics Q4 2024 sees slight EPS miss - Investing.com
SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
SOPHiA GENETICS : Investor PresentationFebruary 2025 -March 04, 2025 at 06:53 am EST - Marketscreener.com
Sophia Genetics earnings missed by $0.02, revenue fell short of estimates - Investing.com UK
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results - PR Newswire
Principal Financial Group Inc. Sells 26,798 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - Defense World
SOPHiA GENETICS (SOPH) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing - PR Newswire
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing -February 24, 2025 at 04:01 am EST - Marketscreener.com
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing – Company Announcement - Financial Times
Global Healthcare Revolution: Elite Hospitals Rush to Implement This Game-Changing Cancer Test - Stock Titan
NeoGenomics plummets on Q4 2024 bottom line miss, soft EPS guidance - MSN
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025 - Marketscreener.com
SOPHiA GENETICS Earnings Preview: AI Healthcare Leader Sets Stage for 2025 Strategic Outlook - Stock Titan
AI In Bioinformatics Market Outlook 2025-2034: Growth Drivers, Share, And Trends - WhaTech
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4%Here's What Happened - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Drop in Short Interest - MarketBeat
10x Genomics falls on quarterly EPS miss, 2025 revenue guidance concern - MSN
3 Promising US Penny Stocks With Market Caps Over $20M - Simply Wall St
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4% – Here’s Why - Defense World
Analyzing Caribou Biosciences (NASDAQ:CRBU) & SOPHiA GENETICS (NASDAQ:SOPH) - Defense World
Clear Channel Outdoor Holdings Inc (CCO) Shares Plummet Below 1-Year High - The News Heater
SOPHiA Genetics SA (SOPH) Stock: Analyzing the Market Value - The News Heater
Anavex Life Sciences Corporation (AVXL) Stock: Assessing the Risk and Reward - The News Heater
Stock market today: Haoxi Health Technology -30.00%, Planet Image International -26.26% among biggest losers in early trading - Business Upturn
SOPHSophia Genetics Sa Latest Stock News & Market Updates - StockTitan
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities -January 28, 2025 at 08:47 am EST - Marketscreener.com
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities – Company Announcement - Financial Times
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities - Barchart
Tempus AI Stock Before Q4 Earnings: To Buy Or Not To Buy? - Barchart
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Sophia Genetics Sa (SOPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
2.27%
자본화:
|
볼륨(24시간):